Hims & Hers Health (HIMS) shares climbed roughly 10% Thursday after an FDA advisory committee voted to place the popular peptide BPC-157 on the compounding…
July 23, 2026
Elevance Health (ELV) delivered a second quarter that, on paper, looked encouraging — the insurer topped earnings estimates and even raised its full-year outlook. Yet…
Morgan Stanley is making an early call ahead of healthcare earnings season: UnitedHealth Group (UNH) will likely top Wall Street’s second-quarter expectations. In a client…
February 27, 2026
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
Shares of OneMedNet Corporation (NASDAQ:ONMD) surged 90% in Friday trading following the announcement of its next commercial launch phase. The company is advancing its Real-World…
February 18, 2026
TRNR Signs Definitive Agreement to Acquire Ergatta, Boosting 2026 Revenue Guidance by 50%
Interactive Strength Inc. (Nasdaq: TRNR), the parent company of Wattbike, FORME, and CLMBR, has finalized a deal to acquire Ergatta, Inc. This move is set…
Hims and Hers’ 2026 Super Bowl ad, “Rich Peiole Live Longer” focused on the health-wealth gap in the United States HIMS & HERS Hims &…
Medtronic (NYSE: MDT) is making a bold move in the transcatheter aortic valve replacement (TAVR) market. The company plans to invest $90 million in Anteris…
September 29, 2025
FDA Approves TREMFYA® for Pediatric Plaque Psoriasis and Psoriatic Arthritis, Marking a Milestone for IL-23 Inhibitors
Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for the treatment of children aged…